118 related articles for article (PubMed ID: 6207846)
1. Degradation of a chromogenic substrate by alpha 2-macroglobulin from plasma of patients with rheumatoid arthritis.
Teodorescu M; Gaspar A; Spear G; Skosey JL; Ganea D
Arthritis Rheum; 1984 Oct; 27(10):1122-9. PubMed ID: 6207846
[TBL] [Abstract][Full Text] [Related]
2. Detection of alpha 2-macroglobulin-associated proteases in the plasma of patients with rheumatoid arthritis.
Gaspar A; Skosey JL; Sequeira W; Teodorescu M
Clin Chem; 1984 Sep; 30(9):1517-22. PubMed ID: 6205792
[TBL] [Abstract][Full Text] [Related]
3. The effect of protease inhibitors on the polyclonal B cell activator from the serum of patients with rheumatoid arthritis.
Teodorescu M; Ganea D; Lee TT; Skosey JL; Rütter G
Int J Immunopharmacol; 1982; 4(1):1-7. PubMed ID: 6177649
[TBL] [Abstract][Full Text] [Related]
4. Plasma from rheumatoid arthritis patients does not contain abnormally high levels of alpha 2-macroglobulin-proteinase complexes.
Davies ME; Coughlan R; Barrett AJ
Arthritis Rheum; 1987 Aug; 30(8):872-7. PubMed ID: 2443146
[TBL] [Abstract][Full Text] [Related]
5. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
[TBL] [Abstract][Full Text] [Related]
6. Active MMPs captured by alpha 2 macroglobulin as a marker of disease activity in rheumatoid arthritis.
Tchetverikov I; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Clin Exp Rheumatol; 2003; 21(6):711-8. PubMed ID: 14740449
[TBL] [Abstract][Full Text] [Related]
7. Can genetic polymorphism of alpha-2-macroglobulin be detected by immunoelectrophoresis? A study using sera, plasma and joint fluids from patients with rheumatoid arthritis and controls.
Dott CS; Howard A
J Immunogenet; 1985 Dec; 12(6):293-300. PubMed ID: 2426367
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor alpha 2-macroglobulin (alpha 2M) and alpha 2M protease complexes.
Dickinson AM; Shenton BK; Alomran AH; Donnelly PK; Proctor SJ
Clin Immunol Immunopathol; 1985 Sep; 36(3):259-65. PubMed ID: 2410170
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions of Leishmania promastigote surface protease with human alpha 2-macroglobulin.
Heumann D; Burger D; Vischer T; de Colmenares M; Bouvier J; Bordier C
Mol Biochem Parasitol; 1989 Feb; 33(1):67-72. PubMed ID: 2469010
[TBL] [Abstract][Full Text] [Related]
10. [Use of the proteinase inhibitor alpha 2-macroglobulin in synovial fluids of arthritis of different origins and its relation to serologic parameters].
Borth W; Menzel EJ; Kubin A; Dunky A; Heckl F
Wien Klin Wochenschr; 1983 Dec; 95(24):873-7. PubMed ID: 6199906
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of hypochlorite-mediated inactivation of proteinase inhibition by alpha 2-macroglobulin.
Wu SM; Pizzo SV
Biochemistry; 1999 Oct; 38(42):13983-90. PubMed ID: 10529245
[TBL] [Abstract][Full Text] [Related]
12. Predominant role of neutrophils in the inactivation of alpha 2-macroglobulin in arthritic joints.
Abbink JJ; Kamp AM; Nieuwenhuys EJ; Nuijens JH; Swaak AJ; Hack CE
Arthritis Rheum; 1991 Sep; 34(9):1139-50. PubMed ID: 1718287
[TBL] [Abstract][Full Text] [Related]
13. Protease binding by alpha 2 macroglobulin in cystic fibrosis.
Bridges MA; Applegarth DA; Johannson J; Wong LT; Davidson AG
Clin Chim Acta; 1982 Jan; 118(1):33-43. PubMed ID: 6172220
[TBL] [Abstract][Full Text] [Related]
14. Anomalous alpha 2-macroglobulin-protease complexes in cystic fibrosis: decreased uptake of the complexes by fibroblasts in culture.
Van Leuven F; Cassiman JJ; Van Den Berghe H
Pediatr Res; 1979 Dec; 13(12):1384-6. PubMed ID: 93265
[TBL] [Abstract][Full Text] [Related]
15. Deposits of alpha 2M in the rheumatoid synovial membrane.
Flory ED; Clarris BJ; Muirden KD
Ann Rheum Dis; 1982 Oct; 41(5):520-6. PubMed ID: 6181747
[TBL] [Abstract][Full Text] [Related]
16. A possible mechanism of immunoregulation produced by alpha 2-macroglobulin.
Alomran A; Shenton BK; Donnelly PK; Francis DM; Proud G; Taylor RM
Ann N Y Acad Sci; 1983; 421():394-7. PubMed ID: 6202210
[TBL] [Abstract][Full Text] [Related]
17. The distribution of enzyme inhibitors in the joint in rheumatoid and experimental arthritis.
Muirden KD; Leyden K
Int J Tissue React; 1984; 6(5):359-65. PubMed ID: 6083987
[TBL] [Abstract][Full Text] [Related]
18. Quantification of functional and inactivated alpha 2-macroglobulin in sepsis.
Abbink JJ; Nuijens JH; Eerenberg AJ; Huijbregts CC; Strack van Schijndel RJ; Thijs LG; Hack CE
Thromb Haemost; 1991 Jan; 65(1):32-9. PubMed ID: 1708920
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
Gonias SL; Balber AE; Hubbard WJ; Pizzo SV
Biochem J; 1983 Jan; 209(1):99-105. PubMed ID: 6189480
[TBL] [Abstract][Full Text] [Related]
20. A solid-phase immunosorbent assay to determine the proteinase binding capacity of alpha 2-macroglobulin using 125I-trypsin as indicator proteinase.
Borth W
Biochim Biophys Acta; 1985 Mar; 838(3):361-9. PubMed ID: 2578825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
